Erratum

Erratum for the Research Article: “Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors” by D. C. Kirouac, J. Y. Du, J. Lahdenranta, R. Overland, D. Yarar, V. Paragas, E. Pace, C. F. McDonagh, U. B. Nielsen, and M. D. Onsum

See allHide authors and affiliations

Science Signaling  30 Sep 2014:
Vol. 7, Issue 345, pp. er5
DOI: 10.1126/scisignal.2005942

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Signaling

Navigate This Article